Fluid Air and Oral Solid Dosage News

Isolation and Drying of Peptides and Oligonucleotides – Improved Production Capacities During Large Scale Manufacturing

Fluid Air delivers cutting-edge PolarDry® electrostatic spray drying technology to enhance efficiency and sustainability in Sinopep Biotech's production process.

This joint effort aims to integrate Fluid Air's groundbreaking electrostatic drying technology into Sinopep's commercial production processes for peptides and oligonucleotides.

Will you be at TIDES Europe next month? Make sure to attend our presentation, Electrostatic Drying Technology and Solvent-Based Therapeutics – Solvent Removal and Drying in a One-Step Process.

Fluid Air is exhibiting at PharmSci 360 in October, and we can’t wait to share how PolarDry® electrostatic drying is revolutionizing the production of pharmaceuticals and therapeutics.

Last week, we attended TIDES USA. More than 130 visitors stopped by our booth or watched our joint presentation, Oligonucleotide Production Capacity Improvement with PolarDry® Electrostatic Drying (ESD) Technology, with Nitto Avecia.

Fluid Air is at TIDES USA this week. If you’re here, too, we’d love to catch up! Stop by booth 837.

Fluid Air is exhibiting at TIDES USA next week, and we can’t wait to share how Polar Dry® electrostatic drying is revolutionizing the production of oligonucleotide and peptide therapeutics.

Join our presentation with Nitto Avecia to review how Electrostatic Drying technology offers a solution to improve the production capacity of oligonucleotides without sacrificing yield in large-scale production.

Presentations highlight business value benefits of electrostatic spray drying for processing thermo-sensitive compounds as compared to conventional spray drying and freeze drying